EMEA-000856-PIP01-10

Key facts

Active substance
Pollen from Dactylis glomarata, Lolium perenne, Phleum pratense, Poa pratensis and Anthoxhantum odoratum (20% each)
Therapeutic area
Pneumology-allergology
Decision number
P/299/2010
PIP number
EMEA-000856-PIP01-10
Pharmaceutical form(s)
Oralmucosal drops
Condition(s) / indication(s)
  • Treatment of rhino-conjuctivitis
  • Treatment of allergic rhinitis
Route(s) of administration
Sublingual use
Contact for public enquiries
ALK-Abelló A/S
ldidk@alk-abello.com
ALKMRPdk@alk-abello.com
Denmark
Phone: +45 457478079
Fax: +45 45748600
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating